Cynthia Schwalm, MBA

 

 

 

 

Owner, EIR Advisory LLC, a life-sciences advisory and investment firm

Cynthia is a recently retired company building biotechnology CEO specializing in commercial/operational strategy, with decades of leadership experience developing, expanding, and breathing life into various organizations such as top tier big pharma/biotech (J&J, Amgen), mid-size specialty pharmaceuticals (Ipsen SA) and start-up biotech environments.  She has been characterized as a forward-thinking leader who advanced from health care provider to CEO while directing nearly every corporate function (medical, regulatory, all commercial operations, manufacturing, and all corporate business functions).  Her reputation for taking decisive action and a holistic, maverick approach to inspiring change and adding value from the patient’s bedside to the boardroom has been instrumental in fueling growth for several publicly traded companies.

Board Service:

Hikma Pharmaceuticals PLC. │FTSE 100: HIK.L   Independent Board Director              ▪ 2019 to pres.
(A multinational generics company focused on oncology injectables)
Member Nominating and Governance and Compensation Committees

Kadmon Group Inc. │ NYSE: KDMN   Independent Board Director                                        ▪ 2019 to pres.
(A clinical stage-stage biopharmaceutical company targeting autoimmune/fibrotic  diseases)
Member of Science and Technology, Compensation and Nominating and Governance Committees 

Caladrius Biosciences Inc. │ NASDAQ: CLBS   Independent Board Director                       ▪ 2018 to pres.
(A clinical stage-stage biopharmaceutical company targeting cardiovascular and autoimmune diseases)
Member of Science and Technology and Audit Committees

G1 Therapeutics Inc.  │ NASDAQ: GTHX           Independent Board Director                   ▪ 2018  to pres.
(A clinical stage biopharmaceutical company focused in oncology)
Chair of Compensation Committee, Member of Nomination and Governance Committee

Sarah Cannon Oncology Research Institute │   Independent Board Director             ▪ 2010 to 2013
(Oncologist owned clinical research org.; successfully acquired by Hospital Corporation of America)

CenterLight Health System  │ Member Board of Directors                                                ▪ 2011 to 2012
(Leading New York City non-for profit health care org. providing community based long term care)

Amerifit Inc. │ Independent Board Director                                                                              ▪ 2007 to 2010
(A privately held nutraceutical consumer company; successfully acquired by Martek/Royal DSM NV)

Professional Affiliations:

National Association of Corporate Directors

Wharton University of Pennsylvania Ben Franklin Society; Leadership Mentor for Wharton Business School MBA Program

Carolina Angel Network

Education:

BSN Nursing  University of Delaware;  Master’s of Business Administration Wharton School of Business, University of Pennsylvania